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Abstract: Natural extracellular matrix (ECM) represents an 
ideal biomaterial for tissue engineering and regenerative 
medicine approaches. For further functionalization, there is a 
need for specific addressable functional groups within this 
biomaterial. Metabolic glycoengineering (MGE) provides a 
technique to incorporate modified monosaccharide derivatives 
into the ECM during their assembly, which was shown by us 
earlier for the production of a modified fibroblast-derived 
dermal ECM. In this study, adipose-derived stem cells (ASCs) 
were treated with the azide-modified monosaccharide derivate 
1,3,4,6-tetra-O-acetyl-N-azidoacetylgalactosamine 
(Ac4GalNAz). Toxicity and viability assays after 24 h and 72 
h incubation revealed high biocompatibility of Ac4GalNAz in 
contact with ASCs. The successful incorporation of the 
functional azide groups into the glycocalyx and the ECM of 
the ASCs was proven by conjugation with a fluorescent dye 
via a copper-catalyzed click reaction. Thus, Ac4GalNAz in 
combination with ASCs was confirmed to achieve an azide-
modified ECM as a multifunctional biomaterial for further 
applications. 
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The extracellular matrix (ECM) represents the natural 
environment of cells in an organism, wherein it is synthesized 
and assembled by tissue-specific cells. Next to native ECM, 
derived from decellularized mature tissues, cell-specific 
matrices can also be obtained from the in vitro culture of these 
cells. Varying with the specific tissue or cell source, the ECM 
contains variable amounts of collagens, other fibrous and non-
fibrous proteins, proteoglycans and glycoproteins and exhibits 
different physical properties. Native and cell-derived ECMs 
are used and studied in a variety of applications as potential 
biomaterials such as cell-influencing coatings [1, 2], hybrid 
scaffolding materials for tissue engineering [3, 4], and bioinks 
[5, 6]. A wide range of potential applications requires the 
modification of the ECM with specific addressable functional 
groups. Chemical modification of ECM compounds is 
challenging as it might affect matrix integrity. To address 
these issues, metabolic glycoengineering (MGE) represents a 
promising tool. This method is based on the incorporation of 
chemically modified monosaccharide derivatives into the 
natural intra- and extracellular oligosaccharide structures of 
the cell by its natural metabolic pathways [7, 8]. These 
functionalities can subsequently be addressed by 
bioorthogonal chemical ligation reactions [9, 10] for tuning 
chemical and physical properties and for visualization of 
glycoconjugates. Previously, we employed MGE with the 
azide-modified monosaccharide derivate 1,3,4,6-tetra-O-
acetyl-N-azidoacetylgalactosamine (Ac4GalNAz) to generate 
a human fibroblast-derived dermal ECM containing azide 
groups [11] that can be addressed by copper-catalyzed azide-
alkyne cycloaddition [12, 13]. For this functionalized ECM 
(clickECM) we could show that the composition and 
functionality of the ECM was not affected by the MGE 
procedure and the modification with azide groups [11]. Later, 
also Gutmann et al. reported a similar approach using the 
corresponding azide-modified glucosamine derivative [14].  
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In this study, we aimed to prove whether the glycocalyx 
and ECM of adipose-derived stem cells (ASCs) can be 
modified with azide groups using Ac4GalNAz in MGE (Figure 
1). Generation of an azide-modified stem cell ECM would be 
very promising for a wide range of applications especially in 
tissue engineering and regenerative medicine by representing 
a stem cell niche material with tunable chemical and physical 
properties. Such a unique biomaterial cannot be achieved by 
decellularization of tissues, as the stem cell niches are very 
small in vivo and integrated in matured neighboring tissues. 
Therefore, azide-modified ECM of ASCs provides multiple 
opportunities of further functionalization and application.  
2 Materials and Methods 
2.1 Isolation and expansion of ASCs 
ASCs were isolated from human tissue samples obtained from 
patients undergoing plastic surgery (Dr. Ziegler; Klinik 
Charlottenhaus, Stuttgart, Germany) as described before [15]. 
All research was carried out in accordance with the rules for 
investigation of human subjects as defined in the Declaration 
of Helsinki. Patients provided written agreement in 
compliance with the Landesärztekammer Baden-Württemberg 
(F-2012- 078, for normal skin from elective surgeries). ASCs 
were initially seeded at a density of 5x103 cells cm-2 in serum-
free MSC growth medium (PELOBiotech, #PB-C-MH-675-
0511-XF) containing 5 % human platelet lysate. 
2.2 Biocompatibility assay 
The biocompatibility of Ac4GalNAz was evaluated by a lactate 
dehydrogenase (LDH) assay (TaKaRa Bio Inc. #630117) and 
a resazurin assay (Sigma Aldrich, #R7017). ASCs were treated 
with 100 µM Ac4GalNAz or phosphate buffered saline (PBS) 
for 24 h and 72 h. LDH assay was performed according to 
manufacturer’s protocol with cell culture supernatant. For the 
resazurin assay, culture medium was changed to medium with 
resazurin salt (11 µg/mL) and incubated for 3 h at 37 °C and 5 
% CO2. 
2.3 Detection of incorporated azide 
groups 
Incorporated azide-groups were detected via copper-catalyzed 
azide-alkyne cycloaddition using an alkyne-linked 
fluorophore as described by Ruff et al. [11]. Isolated 
paraformaldehyde-fixed ECM was stained according to the 
manufacturer’s instructions. Cell nuclei were counterstained 
with 1 μg/mL 4',6-diamidino-2-phenylindole (DAPI, Serva 
Electrophoresis) in PBS for 10 min at RT. Fluorescence 
images (z-stacks) were taken using a Zeiss Axio Observer. 
2.4 Statistics 
All experiments were performed with cells from three 
different biological donors. Data was compared by a one-way 
analysis of variance and a Tukey post-hoc test using OriginPro 
2018b. 
3 Results and Discussion 
Biocompatibility of Ac4GalNAz was proven by LDH and 
resazurin assay (Figure 2). Control groups (Ctr) were 
incubated with PBS and absorption values were normalized to 
the control groups. LDH assay revealed no cytotoxic effects 
of Ac4GalNAz after 24 h and 72 h. 
Figure 1: Schematic overview of the metabolic 
glycoengineering process with ASCs and Ac4GalNAz. Cells 
were grown to confluency followed by the addition of Ac4GalNAz. 
The incorporation of azide-groups into the glycocalyx and ECM 
occurs by MGE. Subsequently the azide-modified ECM was 
isolated by lysis of the cells. Generated azide-modified ECM could 
prospectively be used for further applications such as specific 
modifications of the ECM with molecules and for the use in tissue 
engineering and bioprinting approaches. (Modified after Ruff et al. 
[11]) 
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Metabolization of resazurin salt was comparable for cells 
treated with Ac4GalNAz to the control group. Thus, resazurin 
assay revealed no significant influence of Ac4GalNAz on 
metabolic activity of ASCs. These results are in line with 
previous studies using fibroblasts [11].  
ECM of ASCs can be successfully isolated and harvested 
as thin sheet of protein network (Fig. 3 A;i) or left as thin gel-
like film on the bottom of the petri dish (Figure. 3 A;ii). 
Incorporation of azide-groups into the glycocalyx and ECM of 
ASCs was proven by reaction with fluorophore-linked alkyne. 
In the untreated control group, no specific fluorescence 
staining was observed (Figure 3B). The cells treated with 
Ac4GalNAz exhibited a high specific fluorescence staining of  
the incorporated azide-groups. It was shown that azide groups 
were successfully incorporated into the glycocalyx of the cells. 
Moreover, for ECM isolated from ASCs and thereafter treated 
with Ac4GalNAz, showed a specific fluorescence of stained 
azide groups. This confirmed the incorporation of Ac4GalNAz 
in the stem cell ECM. The azide groups were ubiquitously 
distributed in the glycocalyx and the ECM, comparable to the 
findings of Ruff et al. [11] 
Figure 2: Biocompatibility of Ac4GalNAz in ACSs. ASCs were incubated with 100 µM Ac4GalNAz for 24 h and 72 h. Controls were 
treated with PBS. A: LDH Assay revealed no significant influence of azide-modified monosaccharide on cell death after 24 h and 72 h. 
B: Resazurin assay showed no significant influence of azide-modified monosaccharide on metabolic activity after 24 h and 72 h. 
Figure 3: Characterization of ECM as biomaterial. A: Macroscopic pictures of isolated ECM. i: Isolated ECM floating in PBS. ECM 
can be isolated and collected as a gel-like sheet of a collagen network. ii: Isolated ECM on the bottom of a petri dish. After cell lysis and 
washing steps, the collagen network appears as a gel-like coating on the bottom of a petri dish (d=35 mm) B: Fluorescence staining 
of the incorporated Ac4GalNAz in ASCs and cell-derived ECM. Staining of the azide-groups shows the successful incorporation of 
azide groups into the glycocalyx and ECM of the ASCs. Negative controls (Ctr.) exhibit no fluorescence staining. Cell nuclei are 
counterstained with DAPI. (Scale bar: 100 µm) 
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4 Conclusion 
No negative impact on cell survival and metabolic activity of 
ASCs was detectable. Further, it was shown that stem cell 
ECM of ASCs can be successfully modified with azide groups, 
which can be further addressed by alkyne-groups via copper-
catalyzed azide-alkyne cycloaddition. Based on these results, 
Ac4GalNAz may be considered a suitable azide-modified 
monosaccharide derivative to be used in MGE with ASCs. 
Thereby, this approach opens up a wide field of medical and 
material applications of ASC-derived ECM by yielding a 
multifunctional biomaterial with tuneable chemical and 
physical properties. 
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